Navigation Links
Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
Date:1/12/2009

Primary Businesses

-- Cataract Surgery/IOL: Devices for cataract surgery, which replaces a patient's aging and cloudy natural lens with an IOL or artificial lens to restore vision.

-- Laser Vision Correction (LASIK): Devices used for refractive laser eye surgery to correct myopia (nearsightedness), hyper-opia (farsightedness) and astigmatism (condition that causes blurred vision).

-- Eye Care: Contact lens care products including multi-purpose cleaning and disinfecting solutions, daily cleaners and contact lens rewetting drops; and over-the-counter dry eye products.

Products

-- Cataract Surgery/IOL: WhiteStar Signature(TM) Phacoemulsification System, Healon(R) Viscoelastics, Tecnis(R) Aspheric IOL, Tecnis(R) Multifocal IOL, ReZoom(R) Multifocal IOL, Verisyse(R) Phakic IOL.

-- Laser Vision Correction (LASIK): iLASIK(TM), VISX(TM) Excimer Technology, IntraLase(TM) FS Technology, Advanced CustomVue(TM) Procedure.

-- Eye Care: COMPLETE(R) Multi-Purpose Solution, Blink Contacts(TM) Lubricant Eye Drops, Oxysept(R) UltraCare Formula, Blink(R) Tears Lubricating Eye Drops

Vision Facts

-- About 60 percent of people 60+ years old have cataracts.

-- The global population is aging at unprecedented levels. There are more than 700 million people globally older than 60 (up from 600 million in 2000); by 2020, this number is projected to increase to 1 billion.

-- Cataracts are the leading cause of vision loss among people 55 and older.

-- More than 15 million cataract procedures are performed worldwide annually.

-- Approximately 52 percent of people have some form of myopia or hyperopia.

More than 3.5 million LASIK procedures are performed globally annually; LASIK accounts for more than 90 percent of all U.S. refractive surgical procedures.


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Abbott Announces Earnings Guidance for 2009
2. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
3. Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
4. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
5. Abbott Hosts Conference Call for Third-Quarter Earnings
6. Abbott to Present at UBS Best of Americas Investment Conference
7. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
8. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
9. Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
10. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
11. Abbott Invests Additional $20M in Isis Subsidiary Ibis Biosciences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., STOCKHOLM, November 20 Karol...pean Investment Fund (EIF) has entered into a,co-i...tment fund will be,managed by Karolinska Developme...f early-stage pharmaceutical and medical technolog... in the co-investment fund. The agreement,represen...
(Date:11/19/2009)...le would like to be able to charge their cell phon...too often. A recent discovery made by UC San Diego...ercapacitors that could do just this. , In rece... , Prabhakar Bandaru, a professor in the UCSD Depa...ong with graduate student Mark Hoefer, have found ...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-First... innovator in biotechnology for diabetes therapy, ...ing services to food, supplement, biotechnology an...sed the previously reported $6.3 million registere...,760,870 shares of its common stock and warrants t...
(Date:11/19/2009)... MUNSTER, Germany, November 19 ...led on November 16th, 2009 Flibanserin in the,indi...sia in Parkinson,s,disease for orphan drug status ...EA). Levodopa-induced dyskinesia is a complication... and a serious burden to some of those,affected, s...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...alifax-based consumer health products company reco...Nova Scotia, Jan. 27 Origin BioMed Inc., a privat..., today announced that it has been awarded as one ... , Red Herring Top 100 Global Companies are chosen...itions for North America, Europe and Asia Red Herr...
...EW YORK, Jan. 27 Technology and consulting firm, ...acle Partner Network, today announced year over ye...continue the positive trend in 2009. The company,...f flat to low single digit growth for the U.S. IT...rn affects IT services spending across most indust...
... ST. LOUIS and DURHAM, N.C., Jan. 27 As farmers.... Louis-based Monsanto,(NYSE: MON ) is exploring...e,traits through the seed. Monsanto,s new collabor...ed to do just that by expanding the benefits of,Mo...rmer customer. , Today, Monsanto announced tha...
Other Biology Technology:Origin BioMed Awarded Red Herring Top 100 Global Company 2Origin BioMed Awarded Red Herring Top 100 Global Company 3Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 3New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 4
(Date:11/20/2009)...North Grafton, Mass., November 19, 2009 The estim...industry may be at risk of developing respiratory ...ccording to a questionnaire study undertaken earli...s Cummings School of Veterinary Medicine. , The ...arn workersfound that 50 percent of individuals wo...
(Date:11/20/2009)... This release is available in German . , In...cal Investigation , Dr. Stefanie Eyerich and Dr. K...Imperial College London and Istituto Dermopatico d...ng discovery. It represents a milestone on the way...ory skin diseases such as psoriasis and allergic r...
(Date:11/20/2009)...CHAMPAIGN, Ill. In a new study, researchers repor...ockers can have a helpful, or harmful, effect on t..., The study, which appears in the journal Circul...get both the alpha- and beta-receptors on the hear...s, while those that target only the beta-receptors...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2University of Toronto helps to barcode the worlds plants 9394 1University of Toronto helps to barcode the worlds plants 9394 2Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 1Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
...mproved aerodynamic shape for truck trailers by mo...ption and emissions of up to as much as 15%. Earli...dels and wind tunnel tests by TU Delft, have been ...r. This means that public-private platform PART (P...ced an application which can immediately be put in...
...e most common cause of episodic headache, and by f... visit. It affects some 15% of the population, inc...s a considerable burden on healthcare in both the ... last few years, great strides have been made in d...lity to common diseases, such as diabetes, Crohns ...
...y: New evidence has emerged that, contrary to some... associated with an increased risk of heart proble...cancer recurring. , In a study presented today (T...nce (EBCC-6) in Berlin, the researcher, Dr Alain M...g news for women. , AIs, such as letrozole, anast...
Other Biology News:Aerodynamic trailer cuts fuel and emissions by up to 15 percent 2Concentrating on different aspects of pain leads to breakthrough in migraine genetics 2New research shows no link between aromatase inhibitors and cardiovascular problems 2New research shows no link between aromatase inhibitors and cardiovascular problems 3
Goat Anti-SDF-1 beta / PBSF Polyclonal Antibody, Unconjugated from Sigma-Aldrich
Immulon 4 HBX 1x12 Strip from Thermo Scientific
BspT107 I (HgiC I, Ban I) from Takara Mirus Bio
Enterokinase from bovine intestine from Sigma-Aldrich
Biology Products: